Jerome B Zeldis bought $9,999 of NXGL
director at NEXGEL, INC.. 3,636 shares at an average of $2.75, traded Nov 20, 2024, filed Nov 22, 2024.
Score components
- +15RoleDirector
- 0Trade size$10k at market
- 0Relative to holdingsHoldings up 3.5%
- 0Price contextNo price history yet
- +15Cluster6 insiders buying within 14 days
- 0Repeat buyingFirst buy in 90 days
- 0Track recordToo few past buys to judge (0 with prices)
What happened after comparable buys
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001493152-24-047434, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Nov 20, 2024 | POpen-market purchase Common Stock | +3,636 | $2.75 | $9,999 | 106,664 | Nov 22, 2024 |
| Nov 20, 2024 | AGrant or award Warrant to Purchase Common Stockderivative | +1,818 | $0.00 | $0 | 1,818 | Nov 22, 2024 |
Related signals
Other insiders at NEXGEL, INC. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 0Weak | NEXGEL, INC. | Scott Robert Henry director | $18k 7,697 shares | -6% | |
| 25Weak | NXGLsell NEXGEL, INC. | Adam R. Levy Chief Executive Officer | $9,896 4,000 shares | -1% | |
| 3Weak | NEXGEL, INC. | Scott Robert Henry director | $7,704 3,000 shares | -2% | |
| 33Weak | NEXGEL, INC. | Adam R. Levy Chief Executive Officer | $9,439 4,000 shares | -1% | |
| 33Weak | NEXGEL, INC. | Adam R. Levy Chief Executive Officer | $4,613 2,000 shares | -1% | |
| 33Weak | NEXGEL, INC. | Adam R. Levy Chief Executive Officer | $2,220 1,000 shares | -0% | |
| 33Weak | NEXGEL, INC. | Adam R. Levy Chief Executive Officer | $2,575 1,000 shares | -0% | |
| 3Weak | NEXGEL, INC. | Scott Robert Henry director | $8,062 3,000 shares | -2% | |
| 3Weak | NEXGEL, INC. | Scott Robert Henry director | $7,825 3,000 shares | -2% | |
| 13Weak | NEXGEL, INC. | Adam R. Levy Chief Executive Officer | $12k 4,000 shares | -1% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.